Prescribed Light Exercise for ED Patients With MTBI
A Randomized Controlled Trial Comparing Prescribed Light Exercise to Standard Management for Emergency Department Patients With Acute Mild Traumatic Brain Injury.
1 other identifier
interventional
367
1 country
1
Brief Summary
Introduction: Current guidelines for treating patients with mild traumatic brain injury (MTBI) recommend a period of cognitive rest and gradual return to usual activities with avoidance of any activity that exacerbates symptoms. However, recent studies have reported prolonged rest beyond 48 hours might hinder MTBI recovery, and there is limited evidence to suggest following guidelines has a positive impact on prognosis. Given the paucity of effective management strategies to prevent post-concussion syndrome (PCS) and emerging evidence of the benefits of exercise in MTBI patients, there is an urgent need for more research on the effectiveness of an early exercise intervention in the acute MTBI patient population as prevention of PCS. Research Question: Among adult (18-64 years) patients presenting to the ED with a discharge diagnosis of acute MTBI (defined by the Zurich consensus statement), does prescribing light exercise (ie: 30 min daily walking) reduce the proportion of patients with PCS at 30 days, compared to standard discharge instructions? Methods: This will be a randomized controlled trial of adult (18-64 years) patients discharged from an academic ED diagnosed with MTBI occurring within 48 hours of the index ED visit. The intervention group will receive discharge instructions prescribing 30 minutes of light exercise (ie: walking) and the control group will be instructed to gradually return to activities. Discharge instructions will be read by the attending physician or ED nurse. Patients will be provided a printed copy of the discharge instructions. Depending on their preferences, patients will be contacted by email or by telephone to complete the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), a validated, 16 item questionnaire. The primary outcome of this study will be the proportion of patients with PCS at 30 days, defined as an increase from baseline of ≥ 3 symptoms on the validated RPQ at 1 month. Secondary outcomes will include change in RPQ from baseline to 72 hours, 7 days, 14 days, 30 days post initial ED visit, number of missed days of school or work and repeat visits to a healthcare provider. To assess compliance with ED discharge instructions, patients will be asked to complete a daily activity journal and will be given fitness tracking devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2017
CompletedFirst Posted
Study publicly available on registry
March 20, 2017
CompletedStudy Start
First participant enrolled
June 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2019
CompletedFebruary 20, 2020
February 1, 2020
2.3 years
March 13, 2017
February 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
proportion of patients with PCS
Defined as an increase from baseline of ≥ 3 symptoms on the validated Rivermead Post-Concussion Symptoms Questionnaire
30 days
Secondary Outcomes (3)
Change in RPQ from baseline
72 hours, 7 days, 14 days, 30 days post initial ED visit
Days of school or work missed
72 hours, 7 days, 14 days, 30 days post initial ED visit
Return visits to a health care provider
72 hours, 7 days, 14 days, 30 days post initial ED visit
Study Arms (2)
Control Group
NO INTERVENTIONThe control group will be instructed to gradually return to activities.
Prescribed Light Exercise Group
EXPERIMENTALIntervention: Prescribed Light Exercise Group will receive discharge instructions prescribing 30 minutes of light exercise (ie: walking).
Interventions
Participants in the intervention group will receive discharge instructions prescribing light exercise following mild traumatic brain injury.
Eligibility Criteria
You may qualify if:
- \- MTBI occurring within 48 hours of the index emergency department visit
You may not qualify if:
- Acute intracranial injury identified on head CT
- Multisystem injuries prohibiting light exercise
- Existing medical condition that would compromise ability to participate in light exercise
- GCS \< 15 at time of ED discharge
- Underlying neurological condition resulting in communication difficulties
- Insurmountable language barrier
- Inability to follow-up via telephone
- Alcohol or drug intoxication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Related Publications (1)
Varner CE, Thompson C, de Wit K, Borgundvaag B, Houston R, McLeod S. A randomized trial comparing prescribed light exercise to standard management for emergency department patients with acute mild traumatic brain injury. Acad Emerg Med. 2021 May;28(5):493-501. doi: 10.1111/acem.14215. Epub 2021 Feb 28.
PMID: 33481332DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Varner, MD MSc
Sinai Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician Scientist
Study Record Dates
First Submitted
March 13, 2017
First Posted
March 20, 2017
Study Start
June 19, 2017
Primary Completion
October 3, 2019
Study Completion
October 3, 2019
Last Updated
February 20, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share
No IDP will be shared with other researchers.